研究单位：[1]Capital Medical University[2]Xuanwu Hospital,Capital Medical University Beijing,China,100053[3]Beijing Aerospace General Hospital Beijing,China[4]Beijing Luhe Hospital,Capital Medical University Beijing,China[5]Xiyuan Hospital,China Academy of Chinses Medical Sciences Beijing,China[6]First Hospital of Shanxi Medical Unversity Taiyuan,Shanxi,China[7]Fenyang Hospital of Shanxi Medical Unversity Fenyang,Shanxi,China[8]Peace Hospital Affiliated to Changzhi Medical College Shanxi Province Changzhi,Shanxi,China[9]Zhoushan Putuo Hospital Zhoushan,Zhejiang,China
研究目的：
The primary objective of the study will be to determine whether remote limb ischemic conditioning (RLIC) compared with sham RLIC (placebo) treatment reduces the 12-month risk of recurrent IS in patients with a recent TIA or IS caused by stenosis of a major intracranial artery.
After screening period, eligible patients will be randomly allocated into 2 groups. In addition, all participants receive an usual clinical therapy.
